InvestorsHub Logo
Followers 73
Posts 6235
Boards Moderated 0
Alias Born 05/01/2011

Re: None

Tuesday, 06/25/2024 11:50:34 AM

Tuesday, June 25, 2024 11:50:34 AM

Post# of 429111
Amarin’s outcome is a pimple on the butt of the potential impact of this case on the pharmaceutical industry.

If Amarin wins this puts the entire generic business model in jeopardy.

"The biggest obstacles to our progress exist within our own lives in the form of cowardice and the tendency to give up. Breaking through these barriers will unleash a surging wave of change." -- Daisaku Ikeda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News